227 related articles for article (PubMed ID: 10498880)
1. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
He LZ; Merghoub T; Pandolfi PP
Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
[TBL] [Abstract][Full Text] [Related]
2. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
Merghoub T; Gurrieri C; Piazza F; Pandolfi PP
Blood Cells Mol Dis; 2001; 27(1):231-48. PubMed ID: 11358384
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
4. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
5. Gene rearrangements in the molecular pathogenesis of acute promyelocytic leukemia.
Kalantry S; Delva L; Gaboli M; Gandini D; Giorgio M; Hawe N; He LZ; Peruzzi D; Rivi R; Tribioli C; Wang ZG; Zhang H; Pandolfi PP
J Cell Physiol; 1997 Nov; 173(2):288-96. PubMed ID: 9365539
[TBL] [Abstract][Full Text] [Related]
6. Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.
Sukhai MA; Thomas M; Xuan Y; Chan LS; Hamadanizadeh SA; Zhang T; Bharadwaj RR; Schuh AC; Wells RA; Kamel-Reid S
Oncogene; 2008 Aug; 27(34):4666-77. PubMed ID: 18408763
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylases and transcriptional therapy with their inhibitors.
Pandolfi PP
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S17-9. PubMed ID: 11587360
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.
Rego EM; Pandolfi PP
Semin Hematol; 2001 Jan; 38(1):54-70. PubMed ID: 11172540
[TBL] [Abstract][Full Text] [Related]
9. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
10. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
12. [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids].
Jeanteur P
Bull Cancer; 1998 Apr; 85(4):301-3. PubMed ID: 9752292
[TBL] [Abstract][Full Text] [Related]
13. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
Eclache V; Viguie F; Frocrain C; Cassinat B; Chomienne C; Cymbalista F; Fenaux P
Cancer Genet Cytogenet; 2005 May; 159(1):69-73. PubMed ID: 15860361
[TBL] [Abstract][Full Text] [Related]
14. The theory of APL.
Piazza F; Gurrieri C; Pandolfi PP
Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of the molecular genetics of acute promyelocytic leukemia.
Pandolfi PP
Oncogene; 2001 Sep; 20(40):5726-35. PubMed ID: 11607822
[TBL] [Abstract][Full Text] [Related]
16. Translocations of the RARalpha gene in acute promyelocytic leukemia.
Zelent A; Guidez F; Melnick A; Waxman S; Licht JD
Oncogene; 2001 Oct; 20(49):7186-203. PubMed ID: 11704847
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic reversion in acute promyelocytic leukemia.
Degos L
Nouv Rev Fr Hematol (1978); 1991; 33(6):511-5. PubMed ID: 1667950
[TBL] [Abstract][Full Text] [Related]
19. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
20. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
